Amputation Risk for Diabetics Charlotte NC

The chances of having to have a limb amputated because of diabetes were reduced by 36 percent when people with type 2 diabetes were given the drug fenofibrate to lower their blood fat levels, new research has found.

Vincent Voci
(704) 333-8300
2620 East 7th Street
Charlotte, NC
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
Thomas A Roberts Jr., MD
(704) 377-4009
2015 Randolph Rd
Charlotte, NC
Business
Charlotte Gastroenterology & Hepatology PLLC
Specialties
Gastroenterology

Data Provided by:
Galen Grayson, MD
(704) 295-0001
817 E Morehead St
Charlotte, NC
Business
Genesis Eye Center
Specialties
Ophthalmology

Data Provided by:
Hope Peek, L.Ac., MSOM, Dipl. OM (NCCAOM)
(704) 595-9878
700 East Boulevard
Charlotte, NC
Business
Charlotte Acupuncture and Wellness Center, In
Specialties
Acupuncture, Chinese Herbal Medicine Tui Na Acupressure Nutritional Therapy Thermal Therapies
Doctor Information
Residency Training: Master of Science in Oriental Medicine
Medical School: Southwest Acupuncture College - Santa Fe, NM,
Additional Information
Member Organizations: AAOM NCAAOM


Data Provided by:
Pai Clinic of Chiropractic & Sports Medicine
(704) 599-0900
8821 University East Dr #100
Charlotte, NC

Data Provided by:
ChiroMed Plus
(704) 341-5200
6401 Carmel Rd.
Charlotte, NC

Data Provided by:
Michael Norman
(704) 446-1422
1000 Blythe Blvd
Charlotte, NC
Specialties
Pediatrics

Data Provided by:
Todd Trembula, L.Ac., MSOM, Dipl. OM (NCCAOM)
(704) 595-9878
700 East Boulevard
Charlotte, NC
Business
Charlotte Acupuncture and Wellness Center, In
Specialties
Acupuncture, Chinese Herbal Medicine Tui Na Acupressure Nutritional Therapy Thermal Therapies
Doctor Information
Residency Training: Master of Science in Oriental Medicine
Medical School: Southwest Acupuncture College - Santa Fe, NM,
Additional Information
Member Organizations: AAOM NCAAOM


Data Provided by:
Carolinas Veterinary Medical Hospital
(704) 752-7227
10330 Feld Farm Lane
Charlotte, NC

Data Provided by:
Chiropractic Fitness
(704) 817-4272
8316 Pineville Matthews Rd
Charlotte, NC

Data Provided by:
Data Provided by:

Amputation Risk for Diabetics

Provided By:

THURSDAY, May 21 (HealthDay News) -- The chances of having to have a limb amputated because of diabetes were reduced by 36 percent when people with type 2 diabetes were given the drug fenofibrate to lower their blood fat levels, new research has found.

The study included 9,795 people, ages 50 to 75, who took either 200 milligrams of fenofibrate or a placebo daily for five years. The researchers reported that 115 people had lower-limb amputations attributed to diabetes.

People with previous cardiovascular disease, microvascular disease, previous non-traumatic amputation or skin ulcer, smoking and a longer duration of diabetes were more likely to have amputations than those who had other cardiovascular problems or those who had neither cardiovascular issues or amputations.

The risk of a first amputation was 36 percent lower among people taking fenofibrate than those taking the placebo. The study also found that people in the fenofibrate group had a 47 percent lower risk of amputations below the ankle and without large-vessel disease in the amputated limb. The researchers considered the status of large-vessel disease to distinguish amputations related to large-artery atherosclerosis from those related to diabetic microvascular disease.

The study found virtually no difference in the risk for amputations above the ankle between those who did and did not take fenofibrate.

Height was found to be a major predictor of amputations, with a 1.6-fold increase for every additional 10 centimeters in height.

"Classic markers of macrovascular and microvascular risk were associated with lower-extremity amputations in patients with type 2 diabetes," concluded Professor Anthony Keech, of the National Health and Medical Research Council Clinical Trials Centre at the University of Sydney, in Australia, and his colleagues.

"These findings could lead to a change in standard treatment for the prevention of diabetes-related lower-limb amputations," they concluded, adding that the results "showed a reduction in amputation rates that seemed to emerge after just 1.5 years of fenofibrate use."

The study was published this week in a special issue of The Lancet devoted to diabetes.

More information

The Amputee Coalition of America has more about diabetes and amputation.

SOURCE: The Lancet, news release, May 21, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com